Skip to main content

Anagrelide Side Effects

Medically reviewed by Drugs.com. Last updated on Jan 17, 2024.

Applies to anagrelide: oral capsule.

Serious side effects of Anagrelide

Along with its needed effects, anagrelide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking anagrelide:

More common

Less common

Incidence not known

Other side effects of Anagrelide

Some side effects of anagrelide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to anagrelide: oral capsule.

Nervous system

Very common (10% or more): Headache (43.5%), asthenia (23.1%), dizziness (15.4%), pain (15%)

Common (1% to 10%): Fever

Frequency not reported: Migraine, syncope, somnolence, confusion, insomnia, nervousness, amnesia[Ref]

Cardiovascular

Very common (10% or more): Palpitations (26.1%)

Common (1% to 10%): Chest pain, tachycardia

Frequency not reported: Arrhythmia, cardiovascular disease, angina pectoris, heart failure, postural hypotension, thrombosis, vasodilation

Postmarketing reports: Torsades de pointes, ventricular tachycardia, Prinzmetal angina[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (25.7%), nausea (17.1%), abdominal pain (16.4%), flatulence (10.2%)

Common (1% to 10%): Vomiting, anorexia, dyspepsia, constipation, gastritis, aphthous stomatitis, pharyngitis, hemorrhage, eructation, dehydration[Ref]

General

Very common (10% or more): Edema (20.6%)

Common (1% to 10%): Peripheral edema

Frequency not reported: Tinnitus, flu symptoms, chills[Ref]

Hematologic

Frequency not reported: Anemia, thrombocytopenia, ecchymosis, lymphadenopathy[Ref]

Hepatic

Very rare (less than 0.01%): Cholestatic liver failure

Frequency not reported: Elevated liver enzymes[Ref]

Musculoskeletal

Common (1% to 10%): Back pain

Frequency not reported: Arthralgia, myalgia, leg cramps[Ref]

Respiratory

Very common (10% or more): Dyspnea (11.9%)

Frequency not reported: Pharyngitis, cough, rhinitis, epistaxis, respiratory disease, sinusitis, pneumonia, bronchitis, pleural effusion, pulmonary hypertension, pulmonary infiltrates, asthma, allergic alveolitis[Ref]

Dermatologic

Common (1% to 10%): Rash (including urticaria)

Frequency not reported: Skin disease, alopecia, pruritus[Ref]

Ocular

Frequency not reported: Photosensitivity, amblyopia, abnormal vision, visual field abnormality, diplopia[Ref]

Genitourinary

Frequency not reported: Dysuria, hematuria[Ref]

A 30-year-old man developed erectile dysfunction after 2 months of treatment with anagrelide which disappeared 2 weeks after stopping the drug. A definitive cause could not be determined.[Ref]

Hypersensitivity

The authors of the case report of severe hypersensitivity pneumonitis suggest that patients receiving anagrelide therapy, alone or in combination with hydroxyurea, may benefit from monitoring with serial chest X-rays, pulmonary function testing, and echocardiography to detect the development of cardiomyopathy or hypersensitivity pneumonitis.[Ref]

Very rare (less than 0.01%): A 60-year-old woman developed shortness of breath, palpitations, and chest pain after 1 week of treatment leading to respiratory failure and intubation by week 5. Patient recovered after treatment with methylprednisolone.

Frequency not reported: Severe hypersensitivity pneumonitis[Ref]

Renal

Postmarketing reports: Tubulointerstitial nephritis.

Psychiatric

Frequency not reported: Depression

References

1. Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation. 2001;PROD.

2. Lin S, Howell DN, Tuttle-Newhall JE, Heneghan MA. Cholestatic liver failure secondary to anagrelide. Am J Gastroenterol. 2003;98(9S):S153.

3. Cerner Multum, Inc. UK Summary of Product Characteristics.

4. Braester A, Laver B. Anagrelide-induced erectile dysfunction. Ann Pharmacother. 2002;36:1291.

5. Raghavan M, Mazer MA, Brink DJ. Severe hypersensitivity pneumonitis associated with anagrelide. Ann Pharmacother. 2003;37:1228-31.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.